Form 8-K - Current report:
SEC Accession No. 0001564590-20-010133
Filing Date
2020-03-11
Accepted
2020-03-11 17:22:45
Documents
3
Period of Report
2020-03-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20200311.htm 8-K 33256
2 EX-99.1 xene-ex991_48.htm EX-99.1 12944
3 GRAPHIC ggtezm4ago0q000001.jpg GRAPHIC 8237
  Complete submission text file 0001564590-20-010133.txt   58769
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 20706274
SIC: 2834 Pharmaceutical Preparations